Lipopolysaccharide and interferon gamma activate nuclear factor kappa B and induce cyclo-oxygenase-2 in equine vascular smooth muscle cells

Research in Veterinary Science

Volumn 75, Issue 2, 2003, Pages 133-140

  Janicke, H ^a   Taylor, P M ^a   Bryant, C E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 2; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; DATA ANALYSIS; ENDOTOXEMIA; ENZYME INDUCTION; HORSE; MACROPHAGE ACTIVATION; NONHUMAN; PATHOGENESIS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

BACTERIA (MICROORGANISMS); EQUIDAE;

EID: 0042477505     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-5288(03)00073-0     Document Type: Article

References (35)

1. Alldridge, L.C., Harris, H.H., Plevin, R., Hannon, R., Bryant, C.E., 1999. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. J. Biol. Chem. 274, 37620-37628.
2. Baeuerle, P.A., Henkel, T., 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. Bailey, S.R., Elliott, J., 1999. The role of prostanoids and nitric oxide in endotoxin-induced hyporesponsiveness of equine digital blood vessels. Equine Vet. J. 31, 212-218.
4. Baldwin, A., 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683.
5. Billinghurst, R.C., Fretz, P.B., Gordon, J.R., 1995. Induction of intra-articular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine Vet. J. 27, 208-216.
6. Bishop-Bailey, D., Hla, T., Mitchell, J.A., 1999. Cyclo-oxygenase-2 in vascular smooth muscle. Int. J. Mol. Med. 3, 41-48.
7. Bishop-Bailey, D., Larkin, S., Warner, T.D., Chen, G., Mitchell, J.A., 1997a. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br. J. Pharmacol. 121, 125-133.
8. Bishop-Bailey, D., Pepper, D.J., Haddad, E.B., Newton, R., Larkin, S.W., Mitchell, J.A., 1997b. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arterioscler. Thromb. Vasc. Biol. 17, 1644-1648.
9. Bose, H., 1992. The Rel family: models for transcriptional regulation and oncogenic transformation. Biochem. Biophys. Acta 1114, 1-17.
10. Bryant, C.E., Tomlinson, A., Mitchell, J.A., Thiemermann, C., Willoughby, D.A., 1995. Nitric oxide synthase in the rat fallopian tube is regulated during the oestrous cycle. J. Endocrinol. 146, 149-157.
11. Chen, G., Wood, E., Wang, S.H., Warner, T.D., 1999. Expression of cyclooxygenase-2 in rat vascular smooth muscle cells is unrelated to nuclear factor-kappaB activation. Life Sci. 64, 1231-1242.
12. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., Karin, M., 1996. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304.
13. Frean, S.P., Gettinby, G., May, S.A., Lees, P., 2000. Influence of interleukin-1beta and hyaluronan on proteoglycan release from equine navicular hyaline cartilage and fibrocartilage. J. Vet. Pharmacol. Ther. 23, 67-72.
14. Grilli, M., Chin, J., Lenardo, M.J., 1993. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143, 1-62.
15. Hammond, R.A., Hannon, R., Frean, S.P., Armstrong, S.J., Flower, R.J., Bryant, C.E., 1999. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. Am. J. Vet. Res. 60, 426-431.
16. Henry, M.M., Moore, J.N., 1988. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes. Circ. Shock 26, 297-309.
17. Hood, D.M., Mostafa, M.B., Morgan, S.J., Thomas, B.C., 1993. The role of vascular mechanisms in the development of acute equine laminitis. J. Vet. Intern. Med. 7, 228-234.
18. Hunt, R.J., Grosenbaugh, D.A., Baxter, G.M., Jackman, B.R., Parks, A.H., 1991. Mid-metacarpal deep digital flexor tenotomy in the management of refractory laminitis in horses. Vet. Surg. 20, 15-20.
19. Jourdan, K.B., Evans, T.W., Lamb, N.J., Goldstraw, P., Mitchell, J.A., 1999. Autocrine function of inducible nitric oxide synthase and cyclooxygenase-2 in proliferation of human and rat pulmonary artery smooth-muscle cells: species variation. Am. J. Respir. Cell. Mol. Biol. 21, 105-110.
20. Jungi, T.W., Adler, H., Adler, B., Thony, M., Krampe, M., Peterhans, E., 1996. Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation. Vet. Immunol. Immunopathol. 54, 323-330.
21. Karin, M., Ben-Neriah, Y., 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18, 621-623.
22. Kolyada, A.Y., Savikosky, N., Madias, N.E., 1996. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem. Biophys. Res. Commun. 220, 600-605.
23. Kranzhofer, R., Schmidt, J., Pfeiffer, C.A., Hagl, S., Libby, P., Kubler, W., 1999. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19, 1623-1629.
24. Landry, D.B., Couper, L.L., Bryant, S.R., Lindner, V., 1997. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am. J. Pathol. 151, 1085-1095.
25. Libby, P., Warner, S.J., Friedman, G.B., 1988. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81, 487-498.
26. Liou, H.C., Baltimore, D., 1993. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell Biol. 5, 477-487.
27. Loppnow, H., Bil, R., Hirt, S., Schonbeck, U., Herzberg, M., Werdan, K., Rietschel, E.T., Brandt, E., Flad, H.D., 1998. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91.
28. Morris, D.D., Moore, J.N., Ward, S., 1989. Comparison of age, sex, breed, history and management in 229 horses with colic. Equine Vet. J. Suppl., 129-132.
29. Olson, N.C., Hellyer, P., Dodam, J.R., 1995. Mediators and vascular effects in response to endotoxin. Br. Vet. J. 151, 489-522.
30. Rodgerson, D.H., Belknap, J., Moore, J.N., Fontaine, G.L., 2001. Investigation of mRNA expression of tumor necrosis factor-alpha, interleukin-1beta, and cyclooxygenase-2 in cultured equine digital artery smooth muscle cells after exposure to endotoxin. Am. J. Vet. Res. 62, 1957-1963.
31. Spink, J., Cohen, J., Evans, T.J., 1995. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B. J. Biol. Chem. 270, 29541-29547.
32. Spink, J., Evans, T.J,, 1997. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter. J. Biol. Chem. 272, 24419-24425.
33. Tazawa, R., Xu, X.M., Wu, K.K., Wang, L.H., 1994. Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem. Biophys. Res. Commun. 203, 190-199.
34. Turek, J.J., Lamar, C.H., Fessler, J.F., Bottoms, G.D., 1988. Ultrastructure of equine endothelial cells exposed to endotoxin and flunixin meglumine and equine neutrophils. Am. J. Vet. Res. 48, 1363-1366.
35. Yu, S.M., Wu, J.F., Lin, T.L., Kuo, S.C., 1997. Inhibition of nitric oxide synthase expression by PPM-18, a novel anti-inflammatory agent, in vitro and in vivo. Biochem. J. 328, 363-369.